國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Chagas diseasea clinical approach /

Altcheh, Jaime Marcelo.

Chagas diseasea clinical approach /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Chagas diseaseedited by Jaime Marcelo Altcheh, Hector Freilij.
其他題名:	a clinical approach /
其他作者:	Altcheh, Jaime Marcelo.
出版者:	Cham :Springer International Publishing :2019.
面頁冊數:	xii, 356 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Chagas' diseaseDiagnosis.
電子資源:	https://doi.org/10.1007/978-3-030-00054-7
ISBN:	9783030000547$q(electronic bk.)

Chagas diseasea clinical approach /
Chagas diseasea clinical approach /[electronic resource] :edited by Jaime Marcelo Altcheh, Hector Freilij. - Cham :Springer International Publishing :2019. - xii, 356 p. :ill., digital ;24 cm. - Birkhauser advances in infectious diseases,2504-3811. - Birkhauser advances in infectious diseases..

Overview -- Chapter 1: Chagas disease: past, present and future -- The agent -- Chapter 2: Trypanosoma cruzi Journey from the Insect Vector to the Host Cell -- Chapter 3: A panoramic view of the immune response to Trypanosoma cruzi infection -- Epidemiology -- Chapter 4: Epidemiology of Chagas Disease -- Chapter 5: Chagas Disease in Europe -- Chapter 6: Chagas Disease in the United States (USA) -- Diagnosis -- Chapter 7: Diagnosis of Chagas disease -- Clinical aspects -- Chapter 8: Acute vector-borne Chagas disease -- Chapter 9: Congenital Chagas Disease -- Chapter 10: Chronic Trypanosoma cruzi Infection: Decision Making in the Midst of Uncertainty -- Chapter 11: Orally-Transmitted Chagas Disease: a Neglected Foodborne Infection -- Chapter 12: Gastrointestinal Chagas Disease -- Chapter 13: Chagas in immunosuppressed patients -- Treatment -- Chapter 14: CLINICAL PHARMACOLOGY OF DRUGS FOR THE TREATMENT OF CHAGAS DISEASE -- Chapter 15: In vivo Drug Testing for Experimental Trypanosoma cruzi Infection -- Chapter 16: Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities.

Chagas disease is a potentially life threatening condition that was historically mainly endemic to Latin America. Over the last decade, however, the disease has spread to and is increasingly prevalent in other continents such as North America and Europe, with an estimated 7 million people infected worldwide. It is primarily transmitted by insect vectors that carry the parasite Trypanosoma cruzi, the disease agent. In areas where there is vector control and in non-endemic countries, it is mainly transmitted via congenital infection. Cardiac and gastrointestinal complications are common in untreated individuals.This book offers a comprehensive overview of Chagas disease, including its vectorial and congenital transmission, and molecular diagnosis, which is essential for screening, and developing and providing timely, effective anti-trypanosomal treatment. Written by experts working with infected patients on a daily basis, it discusses the pathogenesis of congenital, cardiac, gastrointestinal and oral Chagas disease, as well as its treatment and the pharmacological aspects of drug development in this area. The chapter, 'Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities' is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.

ISBN: 9783030000547$q(electronic bk.)

Standard No.: 10.1007/978-3-030-00054-7doiSubjects--Topical Terms:

851826
Chagas' disease
--Diagnosis.

LC Class. No.: RC124.4 / .C434 2019

Dewey Class. No.: 616.9363

Chagas diseasea clinical approach /
LDR:03495nmm a2200349 a 4500 001 566228
003 DE-He213
005 20191217163126.0
006 m d
007 cr nn 008maaau
008 200429s2019 gw s 0 eng d
020 $a 9783030000547$q(electronic bk.)
020 $a 9783030000530$q(paper)
024 7 $a 10.1007/978-3-030-00054-7 $2 doi
035 $a 978-3-030-00054-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC124.4 $b .C434 2019
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 616.9363 $2 23
090 $a RC124.4 $b .C433 2019
245 0 0 $a Chagas disease $h [electronic resource] : $b a clinical approach / $c edited by Jaime Marcelo Altcheh, Hector Freilij.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xii, 356 p. : $b ill., digital ; $c 24 cm.
490 1 $a Birkhauser advances in infectious diseases, $x 2504-3811
505 0 $a Overview -- Chapter 1: Chagas disease: past, present and future -- The agent -- Chapter 2: Trypanosoma cruzi Journey from the Insect Vector to the Host Cell -- Chapter 3: A panoramic view of the immune response to Trypanosoma cruzi infection -- Epidemiology -- Chapter 4: Epidemiology of Chagas Disease -- Chapter 5: Chagas Disease in Europe -- Chapter 6: Chagas Disease in the United States (USA) -- Diagnosis -- Chapter 7: Diagnosis of Chagas disease -- Clinical aspects -- Chapter 8: Acute vector-borne Chagas disease -- Chapter 9: Congenital Chagas Disease -- Chapter 10: Chronic Trypanosoma cruzi Infection: Decision Making in the Midst of Uncertainty -- Chapter 11: Orally-Transmitted Chagas Disease: a Neglected Foodborne Infection -- Chapter 12: Gastrointestinal Chagas Disease -- Chapter 13: Chagas in immunosuppressed patients -- Treatment -- Chapter 14: CLINICAL PHARMACOLOGY OF DRUGS FOR THE TREATMENT OF CHAGAS DISEASE -- Chapter 15: In vivo Drug Testing for Experimental Trypanosoma cruzi Infection -- Chapter 16: Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities.
520 $a Chagas disease is a potentially life threatening condition that was historically mainly endemic to Latin America. Over the last decade, however, the disease has spread to and is increasingly prevalent in other continents such as North America and Europe, with an estimated 7 million people infected worldwide. It is primarily transmitted by insect vectors that carry the parasite Trypanosoma cruzi, the disease agent. In areas where there is vector control and in non-endemic countries, it is mainly transmitted via congenital infection. Cardiac and gastrointestinal complications are common in untreated individuals.This book offers a comprehensive overview of Chagas disease, including its vectorial and congenital transmission, and molecular diagnosis, which is essential for screening, and developing and providing timely, effective anti-trypanosomal treatment. Written by experts working with infected patients on a daily basis, it discusses the pathogenesis of congenital, cardiac, gastrointestinal and oral Chagas disease, as well as its treatment and the pharmacological aspects of drug development in this area. The chapter, 'Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities' is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
650 0 $a Chagas' disease $x Diagnosis. $3 851826
650 0 $a Chagas' disease $x Treatment. $3 851827
650 1 4 $a Molecular Medicine. $3 273932
650 2 4 $a Parasitology. $3 194533
650 2 4 $a Infectious Diseases. $3 274275
700 1 $a Altcheh, Jaime Marcelo. $3 851824
700 1 $a Freilij, Hector. $3 851825
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Birkhauser advances in infectious diseases. $3 560251
856 4 0 $u https://doi.org/10.1007/978-3-030-00054-7
950 $a Biomedical and Life Sciences (Springer-11642)